Jonas Holm
Adjungerad universitetsadjunkt
Docent vid HMV. Min forskning strävar efter att förbättra diagnostik och behandling i samband med hjärtkirurgi.
Hjärtsjukvård – rätt behandling vid rätt tidpunkt
Om mig
CV
- Läkarutbildning, Linköpings Universitet 1997
- Specialist Thoraxkirurgi 2006
- Medicine Doktor i Thoraxkirurgi 2013
- Docent i Thoraxkirurgi 2021
Nätverk
- Göteborgs universitet
- NTNU – Norges teknisk-naturvitenskaplige universitet, Trondheim
- Sun Yat-sen University, Guangzhou, Guangdong, China
Publikationer
British Journal of Anaesthesia
, Vol.107
, s.344-350
Vidare till DOI
Journal of Cardiothoracic and Vascular Anesthesia
, Vol.32
, s.245-250
Vidare till DOI
2026
No association between troponin and COPD without cardiovascular influence: findings from a population-based cohort (SCAPIS)
Thorax
(Artikel i tidskrift)
https://dx.doi.org/10.1136/thorax-2025-224120
2025
Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome
New England Journal of Medicine, Vol. 393, s. 2313-2323
(Artikel i tidskrift)
https://dx.doi.org/10.1056/NEJMoa2508026
Copeptin Levels During Cardiac Surgery
Journal of Cardiothoracic and Vascular Anesthesia, Vol. 39, s. 1197-1204
(Artikel i tidskrift)
https://dx.doi.org/10.1053/j.jvca.2025.02.014
2024
Association of Glutamate Infusion With Risk of Acute Kidney Injury After Coronary Artery Bypass Surgery A Pooled Analysis of 2 Randomized Clinical Trials
JAMA Network Open, Vol. 7, Artikel e2351743
(Artikel i tidskrift)
https://dx.doi.org/10.1001/jamanetworkopen.2023.51743
2023
Glutamate infusion associated with reduced rises of p-Copeptin after coronary surgery: Substudy of GLUTAMICS II
Acta Anaesthesiologica Scandinavica, Vol. 67, s. 1373-1382
(Artikel i tidskrift)
https://dx.doi.org/10.1111/aas.14303
Forskning
Huvudansvarig prövare i
CoCAP studien: Coronary CT Angio evaluating Graft Patency in ACS patients treated with DAPT or single ASA after CABG
Coinvestigator i
TACSI studien: Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome
SweVAD studien: Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure